Paper39425201
Cefiderocol pharmacokinetics in critically ill patients undergoing ECMO support.
Marín-Cerezuela M and 8 others. Crit Care, 2024. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cefiderocol pharmacokinetics in critically ill patients undergoing ECMO support. Papers, record 39425201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39425201
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38,667,049 | No Sequestration of Commonly Used Anti-Infectives in the Extracorporeal Membrane Oxygenation (ECMO) Circuit-An Ex Vivo Study. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/38667049 | PubMed |
| 2 | 34,250,190 | Cefiderocol Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemodiafiltration. | Open Forum Infect Dis | 2021 | https://conductscience.org/library/papers/34250190 | PubMed |
| 3 | 37,351,777 | Cefiderocol is Not Sequestered in an Ex Vivo Extracorporeal Membrane Oxygenation (ECMO) Circuit. | Eur J Drug Metab Pharmacokinet | 2023 | https://conductscience.org/library/papers/37351777 | PubMed |
| 4 | 22,722,776 | Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R. | Ther Drug Monit | 2012 | https://conductscience.org/library/papers/22722776 | PubMed |
| 5 | 29,311,072 | Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29311072 | PubMed |
| 6 | 34,071,700 | Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34071700 | PubMed |
| 7 | 33,677,539 | An HPLC assay for the therapeutic drug monitoring of cefiderocol in critically ill patients. | J Antimicrob Chemother | 2021 | https://conductscience.org/library/papers/33677539 | PubMed |
| 8 | 31,724,042 | Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin. | Clin Infect Dis | 2019 | https://conductscience.org/library/papers/31724042 | PubMed |
| 9 | 36,853,601 | Pharmacokinetics of cefiderocol during extracorporeal membrane oxygenation: A case report. | Perfusion | 2023 | https://conductscience.org/library/papers/36853601 | PubMed |
| 10 | 36,498,473 | Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on Obesity, Augmented Renal Clearance, Renal Replacement Therapies, and Extracorporeal Membrane Oxygenation. | J Clin Med | 2022 | https://conductscience.org/library/papers/36498473 | PubMed |
| 11 | 34,383,901 | Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia. | J Antimicrob Chemother | 2021 | https://conductscience.org/library/papers/34383901 | PubMed |
| 12 | 36,215,036 | Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation. | Am J Respir Crit Care Med | 2023 | https://conductscience.org/library/papers/36215036 | PubMed |
| 13 | 34,710,630 | A descriptive case series of pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill patients with documented severe extensively drug-resistant Acinetobacter baumannii bloodstream infection and/or ventilator-associated pneumonia treated with cefiderocol. | J Glob Antimicrob Resist | 2021 | https://conductscience.org/library/papers/34710630 | PubMed |
| 14 | 33,257,454 | Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infection. | Antimicrob Agents Chemother | 2021 | https://conductscience.org/library/papers/33257454 | PubMed |
| 15 | 37,192,727 | Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF). | Int J Antimicrob Agents | 2023 | https://conductscience.org/library/papers/37192727 | PubMed |
| 16 | 38,442,737 | Nosocomial Infections in Adults Receiving Extracorporeal Membrane Oxygenation: A Review for Infectious Diseases Clinicians. | Clin Infect Dis | 2024 | https://conductscience.org/library/papers/38442737 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,375,718 | The Therapeutic Potential of Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Narrative Review. | J Clin Med | 2025 | https://conductscience.org/library/papers/41375718 | PubMed |
| 41,303,095 | Effects of Extracorporeal Membrane Oxygenation Circuits on Drug Sequestration: A Review of Ex Vivo Experiments. | J Clin Med | 2025 | https://conductscience.org/library/papers/41303095 | PubMed |
| 40,145,524 | Towards a holistic approach to pulmonary infections. Insights from the Sixth Annual Meeting of Spanish Experts 2024. | Rev Esp Quimioter | 2025 | https://conductscience.org/library/papers/40145524 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39425201
GET https://conductscience.org/api/papers/v1/39425201/authors